Earnings Summary: A snapshot of McKesson Corporation’s Q1 2024 report

This article was originally published on Alpha Street

McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies, care providers, pharmacies, and governments, on Wednesday reported financial results for the first quarter of 2024.

Earnings Update by AlphaStreet

  • Total revenues came in at $74.5 billion in the first three months of 2024, up 11% year-over-year
  • Earnings per share from continuing operations was $7.02 in Q1, compared to $5.25 last year
  • Adjusted earnings per share increased 25% year-over-year to $7.27
  • McKesson’s board of directors approved a $6.0 billion increase to the company’s share repurchase program
  • For fiscal 2024, the management expects adjusted earnings per share to be between $26.55 and $27.35

The post Earnings Summary: A snapshot of McKesson Corporation’s Q1 2024 report first appeared on AlphaStreet.